{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:58:54Z","timestamp":1786125534654,"version":"build-2736575974"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>Pediatric brain tumors are an incredibly diverse group of neoplasms and neuropathological tumor classification is an essential part of patient care. Classification of pediatric brain tumors has changed considerably in recent years as molecular diagnostics have become incorporated with routine histopathology in the diagnostic process. This article will focus on the fundamental major histologic, immunohistochemical, and molecular features that neuropathologists use to make an integrated diagnosis of pediatric brain tumors. This concise review will focus on tumors that are integral to the central nervous system in pediatric patients including: embryonal tumors, low and high grade gliomas, glioneuronal tumors, ependymomas, and choroid plexus tumors.<\/jats:p>","DOI":"10.1093\/neuros\/nyab182","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T00:42:05Z","timestamp":1620348125000},"page":"7-15","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Neuropathology of Pediatric Brain Tumors: A Concise Review"],"prefix":"10.1227","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3471-1949","authenticated-orcid":false,"given":"Bonnie L.","family":"Cole","sequence":"first","affiliation":[{"name":"Department of Laboratories, Seattle Children's Hospital, Seattle, Washington, USA;"},{"name":"Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"issue":"11","key":"R1-20250819","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/adc.2007.121087","article-title":"Not just small adults: the metaphors of paediatrics","volume":"92","author":"Gillis","year":"2007","journal-title":"Arch Dis Child"},{"issue":"Suppl_4","key":"R2-20250819","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro-Oncol"},{"issue":"7697","key":"R4-20250819","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"},{"issue":"8","key":"R5-20250819","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/annonc\/mdz164","article-title":"Molecular pathology of tumors of the central nervous system","volume":"30","author":"Kristensen","year":"2019","journal-title":"Ann Oncol"},{"issue":"21","key":"R6-20250819","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1002\/cncr.31583","article-title":"Advances in the classification of pediatric brain tumors through DNA methylation profiling: from research tool to frontline diagnostic","volume":"124","author":"Kumar","year":"2018","journal-title":"Cancer"},{"issue":"7663","key":"R7-20250819","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature22973","article-title":"The whole-genome landscape of medulloblastoma subtypes","volume":"547","author":"Northcott","year":"2017","journal-title":"Nature"},{"issue":"5","key":"R8-20250819","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2016.01.015","article-title":"New brain tumor entities emerge from molecular classification of CNS-PNETs","volume":"164","author":"Sturm","year":"2016","journal-title":"Cell"},{"issue":"6","key":"R9-20250819","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol (Berl)"},{"issue":"5","key":"R10-20250819","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/bpa.12866","article-title":"cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors","volume":"30","author":"Ellison","year":"2020","journal-title":"Brain Pathol"},{"issue":"4","key":"R11-20250819","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00401-019-01987-0","article-title":"cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF(V600E) mutation","volume":"137","author":"Ellison","year":"2019","journal-title":"Acta Neuropathol (Berl)"},{"issue":"3","key":"R12-20250819","doi-asserted-by":"crossref","first-page":"e17948","DOI":"10.1371\/journal.pone.0017948","article-title":"BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications","volume":"6","author":"Dias-Santagata","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"R13-20250819","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bpa.12732","article-title":"cIMPACT-NOW: a practical summary of diagnostic points from round 1 updates","volume":"29","author":"Louis","year":"2019","journal-title":"Brain Pathol"},{"issue":"4","key":"R14-20250819","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00401-018-1826-y","article-title":"cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma\/anaplastic astrocytoma, IDH-mutant","volume":"135","author":"Louis","year":"2018","journal-title":"Acta Neuropathol (Berl)"},{"issue":"4","key":"R15-20250819","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/bpa.12832","article-title":"cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading","volume":"30","author":"Louis","year":"2020","journal-title":"Brain Pathol"},{"key":"R16-20250819","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-1-4939-7172-5_5","article-title":"Principles and methods of immunohistochemistry","volume":"1641","author":"Ramos-Vara","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"4","key":"R17-20250819","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ncl.2016.06.014","article-title":"Epidemiology of brain tumors","volume":"34","author":"McNeill","year":"2016","journal-title":"Neurol Clin"},{"issue":"3","key":"R18-20250819","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00401-011-0800-8","article-title":"Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH\/WNT molecular subgroups","volume":"121","author":"Ellison","year":"2011","journal-title":"Acta Neuropathol (Berl)"},{"issue":"58","key":"R19-20250819","doi-asserted-by":"crossref","first-page":"6204","DOI":"10.18632\/oncotarget.27252","article-title":"The predictive capability of immunohistochemistry and DNA sequencing for determining TP53 functional mutation status: a comparative study of 41 glioblastoma patients","volume":"10","author":"Roshandel","year":"2019","journal-title":"Oncotarget"},{"issue":"3","key":"R20-20250819","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/bpa.12837","article-title":"Pathology, diagnostics, and classification of medulloblastoma","volume":"30","author":"Orr","year":"2020","journal-title":"Brain Pathol"},{"issue":"4","key":"R21-20250819","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/jnen\/nlaa005","article-title":"Immunohistochemical and nanoString-Based subgrouping of clinical medulloblastoma samples","volume":"79","author":"D\u2019Arcy","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"R22-20250819","first-page":"87","article-title":"Long non-coding RNA profiling of pediatric medulloblastoma","volume":"13","author":"Kesherwani","year":"2020","journal-title":"BMC Med Genet"},{"issue":"8","key":"R23-20250819","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1172\/JCI64400","article-title":"A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers","volume":"122","author":"Lee","year":"2012","journal-title":"J Clin Invest"},{"issue":"1","key":"R24-20250819","first-page":"74","article-title":"Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors","volume":"59","author":"Biegel","year":"1999","journal-title":"Cancer Res"},{"issue":"6","key":"R25-20250819","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/PAS.0b013e3182196a39","article-title":"Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid\/rhabdoid tumor showing retained SMARCB1 (INI1) expression","volume":"35","author":"Hasselblatt","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"R26-20250819","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00401-014-1323-x","article-title":"SMARCA4-mutated atypical teratoid\/rhabdoid tumors are associated with inherited germline alterations and poor prognosis","volume":"128","author":"Hasselblatt","year":"2014","journal-title":"Acta Neuropathol (Berl)"},{"issue":"2","key":"R27-20250819","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00401-013-1228-0","article-title":"Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity","volume":"128","author":"Korshunov","year":"2014","journal-title":"Acta Neuropathol (Berl)"},{"issue":"6","key":"R28-20250819","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00401-012-1068-3","article-title":"LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR)","volume":"124","author":"Korshunov","year":"2012","journal-title":"Acta Neuropathol (Berl)"},{"key":"R29-20250819","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.76.4720","article-title":"Extensive molecular and clinical heterogeneity in patients with histologically diagnosed CNS-PNET treated as a single entity: a report from the children's oncology group randomized ACNS0332 trial","author":"Hwang","year":"2018","journal-title":"J Clin Oncol"},{"issue":"2","key":"R30-20250819","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s10014-019-00340-3","article-title":"Molecular genetics and therapeutic targets of pediatric low-grade gliomas","volume":"36","author":"Tateishi","year":"2019","journal-title":"Brain Tumor Pathol"},{"issue":"10","key":"R31-20250819","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00381-016-3163-6","article-title":"An integrative molecular and genomic analysis of pediatric hemispheric low-grade gliomas: an update","volume":"32","author":"Lassaletta","year":"2016","journal-title":"Childs Nerv Syst"},{"issue":"1","key":"R32-20250819","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/01913129709023244","article-title":"Ultrastructural pathology of glial brain tumors revisited: a review","volume":"21","author":"Liberski","year":"1997","journal-title":"Ultrastruct Pathol"},{"issue":"5","key":"R33-20250819","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1172\/JCI33656","article-title":"BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas","volume":"118","author":"Pfister","year":"2008","journal-title":"J Clin Invest"},{"issue":"3","key":"R34-20250819","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00401-011-0802-6","article-title":"Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma","volume":"121","author":"Schindler","year":"2011","journal-title":"Acta Neuropathol (Berl)"},{"issue":"8","key":"R35-20250819","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/ng.2682","article-title":"Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma","volume":"45","author":"Jones","year":"2013","journal-title":"Nat Genet"},{"issue":"3","key":"R36-20250819","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/ng.3500","article-title":"MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism","volume":"48","author":"Bandopadhayay","year":"2016","journal-title":"Nat Genet"},{"issue":"6","key":"R37-20250819","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00401-016-1539-z","article-title":"Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology","volume":"131","author":"Qaddoumi","year":"2016","journal-title":"Acta Neuropathol (Berl)"},{"issue":"56","key":"R38-20250819","doi-asserted-by":"crossref","first-page":"95516","DOI":"10.18632\/oncotarget.20764","article-title":"Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1\/TSC2 biallelic inactivation, and no BRAF mutations","volume":"8","author":"Bongaarts","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"R39-20250819","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/ng.2611","article-title":"Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas","volume":"45","author":"Zhang","year":"2013","journal-title":"Nat Genet"},{"issue":"10","key":"R40-20250819","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1158\/1541-7786.MCR-17-0507","article-title":"Desmoplastic infantile ganglioglioma\/astrocytoma (DIG\/DIA) are distinct entities with frequent BRAFV600 mutations","volume":"16","author":"Wang","year":"2018","journal-title":"Mol Cancer Res"},{"issue":"3","key":"R41-20250819","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1750-3639.2012.00582.x","article-title":"Long-term epilepsy-associated tumors","volume":"22","author":"Thom","year":"2012","journal-title":"Brain Pathol"},{"issue":"1","key":"R42-20250819","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40478-018-0551-z","article-title":"The genetic landscape of ganglioglioma","volume":"6","author":"Pekmezci","year":"2018","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"R43-20250819","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/bpa.12081","article-title":"BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors","volume":"24","author":"Prabowo","year":"2014","journal-title":"Brain Pathol"},{"issue":"6","key":"R44-20250819","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00401-016-1549-x","article-title":"Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors","volume":"131","author":"Rivera","year":"2016","journal-title":"Acta Neuropathol (Berl)"},{"issue":"2","key":"R45-20250819","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00401-018-1865-4","article-title":"Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features","volume":"136","author":"Deng","year":"2018","journal-title":"Acta Neuropathol (Berl)"},{"issue":"1","key":"R46-20250819","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00401-015-1493-1","article-title":"Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity","volume":"131","author":"Korshunov","year":"2016","journal-title":"Acta Neuropathol (Berl)"},{"issue":"4","key":"R47-20250819","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer Cell"},{"issue":"5","key":"R48-20250819","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/bpa.12336","article-title":"Diffuse midline gliomas with histone H3-K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations","volume":"26","author":"Solomon","year":"2016","journal-title":"Brain Pathol"},{"issue":"5","key":"R49-20250819","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ccell.2018.04.004","article-title":"Molecular, pathological, radiological, and immune profiling of non-brainstem pediatric high-grade glioma from the HERBY phase II randomized trial","volume":"33","author":"Mackay","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"R50-20250819","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1038\/s41467-019-12187-5","article-title":"Alterations in ALK\/ROS1\/NTRK\/MET drive a group of infantile hemispheric gliomas","volume":"10","author":"Guerreiro Stucklin","year":"2019","journal-title":"Nat Commun"},{"issue":"7","key":"R51-20250819","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1158\/2159-8290.CD-19-1030","article-title":"Infant high-grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes","volume":"10","author":"Clarke","year":"2020","journal-title":"Cancer Discov"},{"issue":"4","key":"R52-20250819","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00401-020-02124-y","article-title":"An update on the CNS manifestations of brain tumor polyposis syndromes","volume":"139","author":"Kim","year":"2020","journal-title":"Acta Neuropathol (Berl)"},{"issue":"12","key":"R53-20250819","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1634\/theoncologist.2017-0242","article-title":"Comprehensive genomic profiling of 282 pediatric low- and high-grade gliomas reveals genomic drivers, tumor mutational burden, and hypermutation signatures","volume":"22","author":"Johnson","year":"2017","journal-title":"Oncologist"},{"issue":"12","key":"R54-20250819","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1177\/0883073815610428","article-title":"Pediatric ependymoma","volume":"31","author":"Vitanza","year":"2016","journal-title":"J Child Neurol"},{"issue":"1","key":"R55-20250819","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.bjc.6603519","article-title":"Stem cells of ependymoma","volume":"96","author":"Poppleton","year":"2007","journal-title":"Br J Cancer"},{"key":"R56-20250819","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-5751-10-7","article-title":"Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts","volume":"10","author":"Ellison","year":"2011","journal-title":"J Negat Results BioMed"},{"issue":"4","key":"R57-20250819","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/1097-0142(19850815)56:4<883::AID-CNCR2820560431>3.0.CO;2-6","article-title":"Myxopapillary ependymoma. A clinicopathologic and immunocytochemical study of 77 cases","volume":"56","author":"Sonneland","year":"1985","journal-title":"Cancer"},{"issue":"1","key":"R58-20250819","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-016-1643-0","article-title":"The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants","volume":"133","author":"Pajtler","year":"2017","journal-title":"Acta Neuropathol (Berl)"},{"issue":"1","key":"R59-20250819","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-0038-1636503","article-title":"Ependymoma","volume":"38","author":"Gerstner","year":"2018","journal-title":"Semin Neurol"},{"issue":"2","key":"R60-20250819","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00401-019-02090-0","article-title":"Molecular characterization of histopathological ependymoma variants","volume":"139","author":"Neumann","year":"2020","journal-title":"Acta Neuropathol (Berl)"},{"issue":"5","key":"R61-20250819","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00401-017-1752-4","article-title":"Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome","volume":"134","author":"Panwalkar","year":"2017","journal-title":"Acta Neuropathol (Berl)"},{"issue":"7489","key":"R62-20250819","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature13109","article-title":"C11orf95-RELA fusions drive oncogenic NF-kappaB signalling in ependymoma","volume":"506","author":"Parker","year":"2014","journal-title":"Nature"},{"issue":"7","key":"R63-20250819","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/neuonc\/now054","article-title":"Toward an integrated histomolecular diagnosis of supratentorial ependymoma","volume":"18","author":"Pajtler","year":"2016","journal-title":"Neuro-Oncol"},{"issue":"1","key":"R64-20250819","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1309\/AJCPPRKNNL09JTLP","article-title":"Diagnostic value of EAAT-1 and Kir7.1 for distinguishing endolymphatic sac tumors from choroid plexus tumors","volume":"138","author":"Schittenhelm","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"R65-20250819","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/BF00307632","article-title":"Clinicopathologic correlations in epithelial choroid plexus neoplasms: a study of 52 cases","volume":"80","author":"Paulus","year":"1990","journal-title":"Acta Neuropathol (Berl)"},{"issue":"12","key":"R66-20250819","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1200\/JCO.2009.26.8169","article-title":"TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors","volume":"28","author":"Tabori","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"R67-20250819","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13148-019-0708-z","article-title":"DNA methylation signature is prognostic of choroid plexus tumor aggressiveness","volume":"11","author":"Pienkowska","year":"2019","journal-title":"Clin Epigenetics"}],"container-title":["Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neurosurgery\/advance-article-pdf\/doi\/10.1093\/neuros\/nyab182\/38594264\/nyab182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ovid.com\/10.1093\/neuros\/nyab182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:57:20Z","timestamp":1786121840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1093\/neuros\/nyab182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1093\/neuros\/nyab182","relation":{},"ISSN":["0148-396X","1524-4040"],"issn-type":[{"value":"0148-396X","type":"print"},{"value":"1524-4040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,10]]},"assertion":[{"value":"2020-10-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}